Salute e Benessere
EVERSANA Expands Global Commercialisation Operations With Berlin, Germany Office
"Over the years we have made smart strategic investments in the services, talent, and locations needed to transform the global commercialisation of life-changing therapies. Germany represents the fourth-largest pharmaceutical market in the world and is often the first country in which our clients strategically launch new therapies in Europe . We have the local expertise and operations in Germany to help our clients and their products thrive," said Jim Lang , CEO, EVERSANA.
The new office opening comes as EVERSANA welcomes clients and health experts from around the world to Berlin in October for the annual Frontiers Health Conference , a two-day gathering of healthcare innovators. Jim Lang , CEO, Roberto Ascione , President, Health Innovation, and Mike Ryan , General Manager in Europe , will be among EVERSANA the speakers at Frontiers Health 2024. For information on how to register, visit frontiers.health and use the code FHEVS20 to save 20%.
EVERSANA is a leading independent provider of global services to the life sciences industry. The company's integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 650 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. To learn more about EVERSANA, visit
eversana.com or connect through
LinkedIn and
X .
Matt Braun
matt.braun@eversana.com
View original content: https://www.prnewswire.co.uk/news-releases/eversana-expands-global-commercialisation-operations-with-berlin-germany-office-302268119.html